🇺🇸 FDA
Company

Aldeyra

Aldeyra Therapeutics

ALDX pharma USA

Quick answer

Aldeyra is a pharma company (ALDX) headquartered in LEXINGTON, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

ADX-102 1% Topical Dermal Cream (reproxalap)

Sjogren-Larsson Syndrome

Phase 3 · small_molecule · completed

1 trials project

ADX-102 Ophthalmic Solution (0.5%)

Non-infectious Anterior Uveitis

Phase 3 · small_molecule · completed

1 trials project

ADX-2191 (intravitreal methotrexate 0.8%)

Proliferative Vitreoretinopathy

Phase 3 · small_molecule · completed

1 trials project

ICM ADX-2191 injection

Primary Vitreoretinal Lymphoma

Phase 3 · small_molecule · active

1 trials project

Reproxalap Ophthalmic Solution (0.25%)

Allergic Conjunctivitis

Phase 3 · small_molecule · completed

4 trials project

Reproxalap Ophthalmic Solution (0.25%)

Dry Eye Disease

Phase 3 · small_molecule · completed

4 trials project

Reproxalap Ophthalmic Solution (0.25%)

Dry Eye

Phase 3 · small_molecule · completed

4 trials project

Reproxalap Ophthalmic Solution (0.25%) QID

Dry Eye

Phase 3 · small_molecule · completed

1 trials project

ADX-102 Ophthalmic Drops (0.5%)

Conjunctivitis, Allergic

Phase 2 · small_molecule · completed

1 trials project

ADX-102 Ophthalmic Solution (0.5%)

Dry Eye Syndromes

Phase 2 · small_molecule · completed

1 trials project

ADX-2191

Retinitis Pigmentosa

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Ethanol Intoxication

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Alcohol Hepatitis

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Plaque Psoriasis

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Nephrotic Syndrome

Phase 2 · small_molecule · terminated

1 trials project

ADX-629

Atopic Asthma

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Chronic Cough

Phase 2 · small_molecule · completed

1 trials project

ADX-629

Covid19

Phase 2 · small_molecule · completed

1 trials project

ADX-629 (Open-label)

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

Active topical NS2 1% dermatologic cream

Sjögren-Larsson Syndrome

Phase 2 · small_molecule · completed

1 trials project

NS2

Non-infectious Anterior Uveitis

Phase 2 · small_molecule · completed

1 trials project

NS2 Ophthalmic Drops (0.5%)

Allergic Conjunctivitis

Phase 2 · small_molecule · completed

1 trials project

Reproxalap Ophthalmic Solution (0.25% Novel Formulation) QID to BID

Dry Eye

Phase 2 · small_molecule · completed

1 trials project

Reproxalap Ophthalmic Solution (0.25%)

Dry Eye Syndrome

Phase 2 · small_molecule · completed

1 trials

Drugs (2)

drug

isoetharine hydrochloride

ISOETHARINE HYDROCHLORIDE

 drug

metaproterenol sulfate

ALUPENT

Patents (8)

patent

US 12240816

Deuterated compounds and uses thereof

Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12128013

Toxic aldehyde related diseases and treatment

Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12097188

Compositions and methods for the treatment of macular degeneration

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12064516

Pharmaceutical formulations and uses thereof

Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12029735

Polymorphic compounds and uses thereof

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12006298

Polymorphic compounds and uses thereof

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12005060

Ophthalmic formulations of methotrexate

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12005061

Ophthalmic formulations of methotrexate

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)